Project documents | Moxetumomab pasudotox for treating hairy-cell leukaemia [ID1142] | Guidance | NICE

Documents

Documents created during the development process.

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 3

Draft scope post referral (PDF 168 KB)

Published:

18 March 2020
Draft matrix post referral (PDF 184 KB)

Published:

18 March 2020

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 2

Draft scope post referral (PDF 218 KB)

Published:

25 July 2018
Draft matrix post referral (PDF 260 KB)

Published:

25 July 2018

Consultation on suggested remit, draft scope and provisional stakeholder list of consultees and commentators: 1

Draft scope post referral (PDF 219 KB)

Published:

18 January 2018
Draft matrix post referral (PDF 259 KB)

Published:

18 January 2018